Patents by Inventor Jay Hesselberth

Jay Hesselberth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200354767
    Abstract: Methods of measuring multiple enzyme activities in parallel in a sequencing-based assay to characterize enzyme activities in individual mammalian cells. In preferred implementations, the methods involve forming microfluidic droplets containing oligonucleotide functionalized microbeads and single mammalian cells, lysing the cells, and allowing enzyme activity on enzyme substrates present in the oligonucleotides, isolating the individual microbeads, and determining the enzymatic activity to quantitate and evaluate the enzymatic activity or capacity of the cells.
    Type: Application
    Filed: November 16, 2018
    Publication date: November 12, 2020
    Inventors: Jay HESSELBERTH, Amanda L. Richer
  • Patent number: 10787703
    Abstract: Genomic DNA contains embedded ribonucleotides (rNMPs) that are incorporated during DNA replication and repair, or formed during DNA damage. The modifications have been linked to genome instability and disease, but no method currently exists to profile their locations genome-wide. rNMP incorporation has been extensively studied in recent years; however, locating sites of rNMP incorporation in genomic DNA has not yet been possible. Disclosed herein is a unique method for mapping rNMPs in genomic DNA that exploits the unique ligation mechanism of Arabidopsis thaliana tRNA ligase (AtRNL), normally involved in tRNA maturation. As disclosed herein AtRNL captures 2?,3?-cyclic phosphate or 2?-phosphate termini of DNA derived from alkaline cleavage of a DNA oligonucleotide (oligo) at an embedded rNMP, ligating the 2?-phosphate end to the 5?-phosphate terminus of the same DNA molecule and producing a ssDNA circle containing an embedded rNMP.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: September 29, 2020
    Assignee: Georgia Tech Research Corporation
    Inventors: Francesca Storici, Jay Hesselberth, Kyung Duk Koh
  • Publication number: 20040126882
    Abstract: Compositions and methods are provided to make, isolate, characterize and use regulatable, catalytically active nucleic acids (RCANA). The present invention is directed to RCANA that transduce molecular recognition into catalysis. Also, RCANAs according to the invention can be used as regulatory elements to control the expression of one or more genes in a metabolic pathway. RCANAs can also be used as regulated selectable markers to create a selective pressure favoring (or disfavoring) production of a targeted bioproduct.
    Type: Application
    Filed: September 24, 2002
    Publication date: July 1, 2004
    Inventors: Andrew D. Ellington, Jay Hesselberth, Kristin Thompson, Michael P. Robertson, Letha Sooter, Eric Davidson, J. Colin Cox, Timothy Riedel, Charles Wilson, Sharon T. Cload, Anthony D. Keefe
  • Publication number: 20030104520
    Abstract: Compositions and methods are provided to make, isolate, characterize and use regulatable, catalytically active nucleic acids (RCANA). RCANA may be used for regulating gene expression and in assays to detect the presence of ligands or to detect activation by an effector of an RCANA bound to a solid support such as a chip or multi-well plate. Also disclosed are compositions and methods for automating the selection procedures of the present invention.
    Type: Application
    Filed: June 14, 2001
    Publication date: June 5, 2003
    Inventors: Andrew D. Ellington, Jay Hesselberth, Kristin A. Marshall, Michael P. Robertson, Letha Sooter, Eric Davidson, J. Colin Cox, Timothy Reidel